Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies
Pancreatic endocrine tumors (PETs) have long fascinated clini-cians, because some can
release biologically active hormones that cause distinct syndromes and provide important …
release biologically active hormones that cause distinct syndromes and provide important …
Central vertigo and dizziness: epidemiology, differential diagnosis, and common causes
M Karatas - The neurologist, 2008 - journals.lww.com
Background: Dizziness is a common complaint among patients seen by primary care
physicians, neurologists, and otolaryngologists. The most common causes of dizziness are …
physicians, neurologists, and otolaryngologists. The most common causes of dizziness are …
[HTML][HTML] Clinical aspects of hereditary hearing loss
A Kochhar, MS Hildebrand, RJH Smith - Genetics in Medicine, 2007 - Elsevier
Hearing loss is an etiologically diverse condition with many disease-related complications
and major clinical, social, and quality of life implications. As the rate of acquired hearing loss …
and major clinical, social, and quality of life implications. As the rate of acquired hearing loss …
The surgical management of symptomatic peripheral nerve sheath tumors
AD Levi, AL Ross, E Cuartas, R Qadir, HT Temple - Neurosurgery, 2010 - journals.lww.com
OBJECTIVE To determine the clinical presentation and morbidity of the surgical
management of peripheral nerve sheath tumors (PNSTs). METHODS We performed a …
management of peripheral nerve sheath tumors (PNSTs). METHODS We performed a …
Neurofibromatosis
PA Gerber, AS Antal, NJ Neumann, B Homey… - European journal of …, 2009 - Springer
Neurofibromatosis (NF) is one of the most common genetic disorders. Inherited in an
autosomal dominant fashion, this phacomatosis is classified into two genetically distinct …
autosomal dominant fashion, this phacomatosis is classified into two genetically distinct …
[HTML][HTML] Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy
Successful treatment of neurofibromatosis type 1 (NF1)-associated tumors poses a
significant clinical challenge. While the primary underlying genetic defect driving RAS …
significant clinical challenge. While the primary underlying genetic defect driving RAS …
Cutaneous manifestations of internal malignancy: diagnosis and management
CE Kleyn, JE Lai-Cheong, HK Bell - American journal of clinical …, 2006 - Springer
An association between systemic malignancy and cutaneous manifestations has long been
recognized. The cutaneous features that can occur are numerous and heterogeneous, and …
recognized. The cutaneous features that can occur are numerous and heterogeneous, and …
Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006)
M Masocco, Y Kodra, M Vichi, S Conti, M Kanieff… - Orphanet journal of rare …, 2011 - Springer
Background Persons affected by neurofibromatosis type 1 (NF1) have a decreased survival,
yet information on NF1-associated mortality is limited. Methods/Aim The National Mortality …
yet information on NF1-associated mortality is limited. Methods/Aim The National Mortality …
Neuropathies in the setting of neurofibromatosis tumor syndromes: complexities and opportunities
Abstract The term 'Neurofibromatosis'(NF) comprises a group of rare diseases with related
clinical presentations but distinct genetic conditions. All currently known types–NF1, NF2 …
clinical presentations but distinct genetic conditions. All currently known types–NF1, NF2 …
A 38-year review of oral schwannomas and neurofibromas in a Brazilian population: clinical, histopathological and immunohistochemical study
GJF do Nascimento… - Clinical oral …, 2011 - Springer
The benign peripheral nerve sheath tumours are rare lesions mainly represented by
schwannoma and neurofibroma. The present work evaluated the clinical and …
schwannoma and neurofibroma. The present work evaluated the clinical and …